Hjem › Adenokarcinom i spiserøret › California
Kliniske studier for Adenokarcinom i spiserøret i California
22 studier for Adenokarcinom i spiserøret søker deltakere på steder i California.
Byer i California
- Baldwin Park9 studier
- Los Angeles9 studier
- Orange7 studier
- Irvine4 studier
- Concord4 studier
- Newport Beach4 studier
- San Francisco4 studier
- Santa Monica4 studier
- Oakland4 studier
- San Diego3 studier
- San Jose3 studier
- Santa Rosa3 studier
Offisiell studietekst (engelsk)
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- City of Hope, Duarte
- Hoag Memorial Hospital Presbyterian, Newport Beach
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07544589Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Kaiser Permanente-Anaheim, Anaheim
- Kaiser Permanente-Baldwin Park, Baldwin Park
- Kaiser Permanente-Bellflower, Bellflower
- og 37 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Kaiser Permanente-Deer Valley Medical Center, Antioch
- PCR Oncology, Arroyo Grande
- Sutter Auburn Faith Hospital, Auburn
- og 61 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05677490A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- City of Hope National Medical Center, Duarte
- City of Hope at Irvine Lennar, Irvine
- Ronald Reagan UCLA Medical Center, Los Angeles
- og 3 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07090499A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- USC/Norris Comprehensive Cancer Center, Los Angeles
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
- Local Institution - 0428, San Francisco
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07221149Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- The Oncology Institute of Hope and Innovation, Cerritos
- Ellison Medical Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
- og 3 flere
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06324357Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- UCLA Hematology/Oncology - Atascadero, Atascadero
- UCLA Hematology/Oncology - Burbank, Burbank
- UCLA Hematology/Oncology - Encino, Encino
- og 5 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07392892A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Duarte, Duarte
- Providence Medical Foundation, Santa Rosa
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07277413Lucid Registry Study
- LUCID DX, Lake Forest
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05965999Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- University of California, Los Angeles, Los Angeles
- Kaiser Permanente Oakland Medical Center, Oakland
- Kaiser Permanente, San Jose
Rekrutterer
Alder 18 til 89 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT05753748A Study of KK2269 in Adult Participants With Solid Tumors
- City Of Hope National Medical Center, Duarte
- Hoag Memorial Hospital Presbyterian, Newport Beach
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06266299Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Duarte
- Research Site, Fountain Valley
- Research Site, Fullerton
- og 5 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07431281Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- University of California, San Francisco, San Francisco
- John Muir Medical Center-Walnut Creek, Walnut Creek
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT04221893A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Los Angeles Cancer Network, Los Angeles
- Pih Health Hematology Medical Oncology, Whittier
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT06330064A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- City of Hope, Duarte
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jul. 2026 · NCT06657144ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT06824363A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Providence Medical Foundation, Anaheim
- Providence Medical Foundation, Fullerton
- Providence St. Jude Medical Center Virginia K Crosson and Infusion Center, Fullerton
- og 7 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT04389632Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
- Kaiser Permanente, Oakland
Rekrutterer
Alder 18 til 89 · Alle kjønn · Oppdatert 1. jul. 2026 · NCT05530343First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, Duarte
- Research Site, Orange
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT07284186Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
- I-MAB Site 1005, Duarte
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. mai 2026 · NCT07432295Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- Stern Center for Cancer Clinical Trials and Research, Orange
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mar. 2026 · NCT04900818A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
- VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. nov. 2025 · NCT05563766Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.